MENU
AUPH
AS OF
Dec 12 closing price
Price
$15.85
Change
-$0.03 (-0.19%)
Capitalization
2.09B
80 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
AUPH
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Aurinia Pharmaceuticals (AUPH) Ownership - Who owns Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
14315 118 Avenue
Phone
+1 250 708-4272
Employees
300
Web
https://www.auriniapharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.09B
P/E Ratio
28.30
Total Cash
351.81M
Projected Growth
N/A
Total Debt
78.21M
Revenue
265.81M
Risk (Beta)
2.30
Dividend Yield
N/A
Total Cash/Share
2.67
Total Debt/Equity
N/A
Revenue/Share
1.88 USD as % of share price

Fundamentals

AUPH
Capitalization
2.09B
P/E Ratio
28.30
Risk (Beta)
2.30
Dividend Yield
N/A
Total Cash
352M
Total Cash/Share
2.67
Total Debt
78.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.88%
Revenue
266M
ROE
N/A
Book Value
366M
P/B Ratio
5.71
Cash Flow
N/A
Earnings
0.58
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.12B
Current Ratio
5.76
Current Revenue Per Employee
233360.00
Dividends Per Share - Security
N/A
EBITDA
104M
Float
N/A
Float - Current
N/A
Gross Income Margin
88.87
Revenue To Assets
14.46
Shares Held By Institutions
992M
Shares Outstanding - Current
132M
Total Liabilities
162M
Total Volume MTD
N/A
Value
-1
Gain YTD
76.837
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
AUPH
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AUPH showed earnings on November 04, 2025. You can read more about the earnings report here.
View AI-Driven Trading for AUPH
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
14315 118 Avenue
Phone
+1 250 708-4272
Employees
300
Web
https://www.auriniapharma.com